Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.41 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.32 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.31 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24031427 | 0.97 | CA1 (0.43) | CA1CA2CA4TRPA1TRPM8 | |
| SCHEMBL598497 | 0.94 | — | — | |
| Formamide SCHEMBL28320537 | 0.86 | TRPA1 (0.38) | CA1CA2CA4TRPA1TRPM8 | |
| SCHEMBL20693175 | 0.82 | CA1 (0.46) | CA1CA2CA4TRPA1TRPM8 | |
| SCHEMBL16191287 | 0.82 | CA1 (0.46) | CA1CA2CA4TRPA1TRPM8 | |
| SCHEMBL26224684 | 0.81 | TRPA1 (0.42) | CA1CA2CA4TRPA1TRPM8 | |
| SCHEMBL11361007 | 0.79 | CA1 (0.48) | CA1CA2CA4EPHX1 | |
| SCHEMBL4365281 | 0.78 | TRPA1 (0.38) | CA1CA2CA4TRPA1TRPM8 | |
| SCHEMBL6236455 | 0.78 | CA1 (0.48) | CA1CA2CA4TRPA1TRPM8 | |
| SCHEMBL23797524 | 0.78 | CA1 (0.42) | CA1CA2CA4EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260049264-A1 | CHEMICAL SOLUTION AND CHEMICAL SOLUTION-HOUSING ARTICLE | FUJIFILM CORP (JP) | 2026-02-19 | — | — | US | claimed |
| WO-2024237109-A1 | CHEMICAL SOLUTION AND CHEMICAL-SOLUTION-ACCOMMODATING BODY | 富士フイルム株式会社 | 2024-11-21 | — | — | WO | claimed |
| US-11795277-B2 | Polyolefin-based polymer nanocomposite containing zinc oxide particles and method of producing same | TOSOH FINECHEM CORPORATION (JP) | 2023-10-24 | — | — | US | claimed |
| EP-2829555-B1 | METHOD FOR PRODUCING OLEFIN POLYMER | MITSUI CHEMICALS INC (JP) | 2018-05-16 | — | — | EP | claimed |
| US-9315602-B2 | Method for producing olefin polymer | MITSUI CHEMICALS, INC. (JP) | 2016-04-19 | — | — | US | claimed |
| US-5587354-A | MIXTURE OF A TERPENE AND OIL | INTEGRITY INDUSTRIES, INC. (US) | 1996-12-24 | — | — | US | claimed |
| EP-0366042-A2 | Adsorbent for optical resolution and resolution method employing it | MITSUBISHI KASEI CORPORATION (JP) | 1990-05-02 | — | — | EP | claimed |
| US-20260062631-A1 | CYCLOOCTANE CONTAINING FUEL COMPOSITIONS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2026-03-05 | — | — | US | disclosed |
| US-20260049264-A1 | CHEMICAL SOLUTION AND CHEMICAL SOLUTION-HOUSING ARTICLE | FUJIFILM CORP (JP) | 2026-02-19 | — | — | US | disclosed |
| US-20260047994-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | SYMRISE AG (DE) | 2026-02-19 | — | — | US | disclosed |
| US-20260018421-A1 | SUBSTRATE PROCESSING METHOD, AND SUBSTRATE MANUFACTURING METHOD | CENTRAL GLASS CO LTD (JP) | 2026-01-15 | — | — | US | disclosed |
| US-12503662-B1 | Cyclooctane containing seal swelling compositions and methods for use of same | CleanJoule, Inc. (US) | 2025-12-23 | — | — | US | disclosed |
| US-20250343040-A1 | SUBSTRATE PROCESSING METHOD AND SUBSTRATE PRODUCTION METHOD | CENTRAL GLASS CO LTD (JP) | 2025-11-06 | — | — | US | disclosed |
| WO-2003051298-A2 | PREPARATION OF INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANTIVIRAL NUCLEOSIDES | PHARMASSET LTD. (BB) | 2003-06-26 | — | — | WO | disclosed |
| US-6547863-B2 | Having stability and concentration fit for solution chemical vapor deposition by utilizing cyclohexane based compounds which disolve said metal compound | ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) | 2003-04-15 | — | — | US | disclosed |
| US-20010022148-A1 | Metal compound solution and thin film formation using the same | ASAHI DENKA KOGYO KABUSHIKI KAISHA | 2001-09-20 | — | — | US | disclosed |
| CN-1309192-A | Metal compound solution and method for preparing film using same | ASAHI ELECTROCHEMICAL INDUSTRY (JP) | 2001-08-22 | — | — | CN | disclosed |
| US-5759528-A | AMINE OXIDE SURFACTANT AND CYCLOHEXANE, CYCLOHEXENE OR CYCLOHEXANONE DERIVATIVE | INSTITUTE FOR ADVANCED SKIN RESEARCH, INC. (JP) | 1998-06-02 | — | — | US | disclosed |
| US-5587354-A | MIXTURE OF A TERPENE AND OIL | INTEGRITY INDUSTRIES, INC. (US) | 1996-12-24 | — | — | US | disclosed |
| EP-0745389-A1 | COMPOSITION FOR TOPICAL APPLICATION | INSTITUTE FOR ADVANCED SKIN RESEARCH INC. (JP) | 1996-12-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260049264-A1 | CHEMICAL SOLUTION AND CHEMICAL SOLUTION-HOUSING ARTICLE | OR10J3, PPM1D, PPM1F | CA1 729/4885CA2 1671/4885CA4 2117/4885 |
| US-12503662-B1 | Cyclooctane containing seal swelling compositions and methods for use of same | AQP1, GJA1, DSC1 | CA1 1301/4885CA2 1809/4885CA4 3514/4885 |
| US-11795277-B2 | Polyolefin-based polymer nanocomposite containing zinc oxide particles and method of producing same | LIPA, ZNF787, TLL1 | CA1 381/4885CA2 3989/4885CA4 2836/4885 |
| US-20260018421-A1 | SUBSTRATE PROCESSING METHOD, AND SUBSTRATE MANUFACTURING METHOD | ESPL1, SMS, SGMS1 | CA1 60/4885CA2 786/4885CA4 504/4885 |
| US-20260047994-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | RBP4, LRAT, RARB | CA1 1939/4885CA2 1876/4885CA4 1688/4885 |
| US-20260062631-A1 | CYCLOOCTANE CONTAINING FUEL COMPOSITIONS | CPT1A, CPT2, CNR2 | CA1 2071/4885CA2 1134/4885CA4 1129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.